Implementation of new tests and treatments for patients with advanced triple negative breast cancer in routine care – data from the registry platform OPAL 3. Dezember 2022 Zahn MO, Welt A, Thill M, Stickeler E, Zaiss M, Nusch A, u. a. Oncol Res Treat. 2022;45(suppl 1)(246):23. Download First results from the prospective national intersectoral cohort study JADE to assess characteristics, treatment and outcome of patients with hepatocellular or cholangiocellular carcinoma in Germany. Thimme R., Schröder J., Uhlig J., Freiberg-Richter J., Zingerle M.; Schlenska-Lange A., Hering-Schubert C., Potthoff K., Bengsch F., Hillebrand L.E., Siebenbach H.U., Jänicke M., Hofmann… Weiterlesen RAS mutant metastatic colorectal cancer – Real-world data from more than 1000 patients from the Clinical Tumor Registry Colorectal Cancer (TKK). Dörfel S, Bernhardt C, Eggers E, Fruehauf S, Maintz C, Behringer J, u. a. Oncol Res Treat. 2022;45(suppl 1)(245):64. Download… Weiterlesen